Published in
PAGEpress, Reumatismo, 1(71), p. 37-41, 2019
DOI: 10.4081/reumatismo.2019.1041
Links
Tools
Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases
Journal article published in 2019 by
E. Mauro,
E. Garlatti Costa,
A. Zanier,
M. Maset,
A. Ermacora,
M. Ghersetti,
P. Casarin
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Acquired haemophilia A (AHA) is a rare bleeding disorder due to autoantibodies directed against coagulation factor VIII. The treatment is based on recombinant activated factor VII and activated prothrombin complex concentrate. However, mainly in older patients, severe thrombotic complications have been reported. Here we report the different therapeutic approaches in 4 cases of elderly patients with AHA and co-morbidities.